bioAffinity Technologies, Inc. (BIAF) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the bioAffinity Technologies, Inc. stock forecast from 0 analysts, the average analyst target price for bioAffinity Technologies, Inc. is not available over the next 12 months. bioAffinity Technologies, Inc.’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of bioAffinity Technologies, Inc. is Bearish, which is based on 1 positive signals and 8 negative signals. At the last closing, bioAffinity Technologies, Inc.’s stock price was USD 0.28. bioAffinity Technologies, Inc.’s stock price has changed by -24.69% over the past week, -66.70% over the past month and -87.02% over the last year.
No recent analyst target price found for bioAffinity Technologies, Inc.
No recent average analyst rating found for bioAffinity Technologies, Inc.
Company Overview bioAffinity Technologies, Inc.
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung. It offers CyPath lung, a diagnostic test, for early detection of lung cancer. The company was incorporated in 2014 and is based in San Antonio, Texas. Read Less
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung. It offers CyPath lung, a diagnostic test, for early detection of lung cancer. The company was incorporated in 2014 and is based in San A...Read More
Frequently Asked Questions About bioAffinity Technologies, Inc. (BIAF) Stock
Stock Target Advisor's fundamental analysis for bioAffinity Technologies, Inc.'s stock is Bearish.
Unfortunately we do not have enough data on BIAF's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on BIAF's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on BIAF's stock to indicate if its overvalued.
The last closing price of BIAF's stock was USD 0.28.
The most recent market capitalization for BIAF is USD 0.02B.
Unfortunately we do not have enough analyst data on BIAF's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains bioAffinity Technologies, Inc.'s stock.
As per our most recent records bioAffinity Technologies, Inc. has 75 Employees.
bioAffinity Technologies, Inc.'s registered address is 22211 West Interstate 10, San Antonio, TX, United States, 78257.
You can get more information about it from bioAffinity Technologies, Inc.'s website at https://www.bioaffinitytech.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About bioAffinity Technologies, Inc. (BIAF) Stock
Stock Target Advisor's fundamental analysis for bioAffinity Technologies, Inc.'s stock is Bearish.
Unfortunately we do not have enough data on BIAF's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on BIAF's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on BIAF's stock to indicate if its overvalued.
The last closing price of BIAF's stock was USD 0.28.
The most recent market capitalization for BIAF is USD 0.02B.
Unfortunately we do not have enough analyst data on BIAF's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains bioAffinity Technologies, Inc.'s stock.
As per our most recent records bioAffinity Technologies, Inc. has 75 Employees.
bioAffinity Technologies, Inc.'s registered address is 22211 West Interstate 10, San Antonio, TX, United States, 78257.
You can get more information about it from bioAffinity Technologies, Inc.'s website at https://www.bioaffinitytech.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BIAF !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
